back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-14 13:59 Tx date 2025-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-400,000
-50,000 vol $8.00 each |
1,244,250 | |
| Filed 2025-03-27 13:59 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,336,400
+260,000 vol $5.14 each |
1,294,250 | |
| Filed 2024-05-22 23:21 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,584,000
+400,000 vol $3.96 each |
1,034,250 | |
| Filed 2023-08-20 00:35 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,002
+14,286 vol $7.00 each |
674,012 | |
| Filed 2023-03-29 11:22 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,894
+700 vol $4.14 each |
659,726 | |
| Filed 2023-03-29 11:21 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,463
+600 vol $4.11 each |
659,026 | |
| Filed 2023-03-29 11:19 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,680
+4,800 vol $4.10 each |
658,426 | |
| Filed 2022-12-12 19:55 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$731,500
+190,000 vol $3.85 each |
634,250 | |
| Filed 2022-08-25 02:39 Tx date 2022-08-22 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,819
+6,800 vol $1.15 each |
653,626 | |
| Filed 2022-08-22 12:47 Tx date 2022-08-19 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$770.00
+700 vol $1.10 each |
646,826 | |
| Filed 2022-08-20 11:20 Tx date 2022-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,925
+8,500 vol $1.05 each |
646,126 | |
| Filed 2022-08-17 17:38 Tx date 2022-08-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,625
+2,500 vol $1.05 each |
637,626 | |
| Filed 2022-07-02 12:36 Tx date 2022-06-29 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+9,900 vol $1.00 each |
635,126 | |
| Filed 2022-06-14 16:27 Tx date 2022-06-14 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+10,000 vol $1.20 each |
625,226 | |
| Filed 2022-04-23 01:38 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$9,000
+30,000 vol $0.30 each |
180,000 | |
| Filed 2022-04-23 01:37 Tx date 2022-04-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$52,500
+30,000 vol $1.75 each |
615,226 | |
| Filed 2022-04-01 19:02 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,945
+2,208 vol $2.24 each |
585,226 | |
| Filed 2022-04-01 19:01 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,575
+2,500 vol $2.23 each |
583,018 | |
| Filed 2022-04-01 19:01 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,998
+2,272 vol $2.20 each |
580,518 | |
| Filed 2022-04-01 19:00 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$876.00
+400 vol $2.19 each |
578,246 | |
| Filed 2022-04-01 19:00 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,917
+1,396 vol $2.09 each |
577,846 | |
| Filed 2022-04-01 18:59 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,416
+1,700 vol $2.01 each |
576,450 | |
| Filed 2022-04-01 18:54 Tx date 2022-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$269,800
+142,000 vol $1.90 each |
444,250 | |
| Filed 2021-08-24 15:50 Tx date 2021-08-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,967
+650 vol $3.03 each |
574,750 | |
| Filed 2021-08-24 15:49 Tx date 2021-08-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$321.00
+100 vol $3.21 each |
574,100 | |
| Filed 2021-08-24 15:48 Tx date 2021-08-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,508
+24,000 vol $3.02 each |
574,000 | |
| Filed 2021-03-12 19:22 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
100,500 | ||
| Filed 2021-03-12 19:21 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-03-12 19:15 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$1,350,000
+168,750 vol $8.00 each |
302,250 | |
| Filed 2021-03-12 19:08 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
133,500 | ||
| Filed 2021-03-12 19:07 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
550,000 |